Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302Eur. J. Cancer 2022 May 11;[EPub Ahead of Print], BE Wilson, AJ Armstrong, J de Bono, CN Sternberg, CJ Ryan, HI Scher, MR Smith, D Rathkopf, CJ Logothetis, KN Chi, RJ Jones, F Saad, P De Porre, N Tran, P Hu, S Gillessen, J Carles, K Fizazi, AM Joshua
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.